PNEUMOCOCCAL VACCINES
Clinical trials for PNEUMOCOCCAL VACCINES explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL VACCINES trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL VACCINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 26-Valent pneumonia vaccine shows promise in early trials
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine that protects against 26 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 450 people aged 2 months and older received the vaccine to check its safety and how well it triggers the immune system. The trial…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE1, PHASE2 • Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC
-
New vaccine aims to shield infants from 24 pneumococcal strains
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called VAX-24 that protects against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. About 800 healthy infants received four doses of either VAX-24 or a current vaccine at 2, 4, 6, and 12-15 month…
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE2 • Sponsor: Vaxcyte, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:55 UTC
-
New 25-Valent vaccine aims to broaden protection against pneumococcal disease
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to protect against 25 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 220 healthy adults aged 18 to 49 received either the new vaccine or an existing one to compare safety and immune response. …
Matched conditions: PNEUMOCOCCAL VACCINES
Phase: PHASE2 • Sponsor: Inventprise Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 13, 2026 16:00 UTC